Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncoimmunology. 2013 Jan 1;2(1):e22448.

The adenosinergic system in cancer: Key therapeutic target.

Author information

1
Department of Pharmaceutical and Biomedical Sciences; University of Salerno; Salerno, Italy.

Abstract

High amounts of adenosine are released in the tumor mass. Depending on the levels of adenosine, as well as on the receptor subtypes that are expressed by immune cells, adenosine can affect tumor growth in different fashions. Specifically targeting CD73, the rate-limiting enzyme for the extracellular generation of adenosine, or the A3 receptor offers new therapeutic strategies to limit tumor progression.

KEYWORDS:

ATP; CD73; adenosine; adenosine receptors; tumor immunity

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center